COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2)
Conditions:   Migraine;   Patent Foramen Ovale Interventions:   Device: PFO device closure;   Drug: Aspirin Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 30, 2022 Category: Research Source Type: clinical trials

The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study
Condition:   Migraine Intervention:   Drug: observational study Sponsor:   PeriPharm Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2022 Category: Research Source Type: clinical trials

Pulmatrix Announces Patient Dosing Completed for its Novel Inhaled Therapy PUR3100 for Acute Migraine
LEXINGTON, Mass., Sept. 26, 2022. Pulmatrix, Inc., a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease using its patented iSPERSE technology, today announced that all subjects have completed... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 26, 2022 Category: Pharmaceuticals Source Type: clinical trials

Postdural Puncture Headache Relief With Aminophylline and SPGB
Condition:   Anesthesia Interventions:   Other: conservative therapy;   Drug: Aminophylline;   Procedure: trans nasal sphenopalatine ganglion block Sponsor:   Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2022 Category: Research Source Type: clinical trials